Overview

A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This is a phase 1, open label, two-cohort, single-sequence, crossover study
Phase:
Phase 1
Details
Lead Sponsor:
Yuhan Corporation
Treatments:
Amlodipine
Rosuvastatin Calcium
Telmisartan
Telmisartan amlodipine combination